van Greevenbroek MM, Schalkwijk CG, Stehouwer CD
Four states eliminated coverage in that window: California, New Hampshire, Pennsylvania, and South Carolina
In Quebec, where one in four adults is obese, the current cost of these new drugs (approximately $500 per month) would involve an annual expenditure of several hundred million dollars (in the United States the situation is even worse: the cost of a 72-week course of tirzepatide (15 mg/week) is approximately US$17,000, while the 68-week treatment with semaglutide (2.4 mg/week) is nearly US$23,000!)
A Closer Look at the Dermatological Profile of GLP-1 Agonists
Specifically, TBK1 exerts its regulatory function through two major pathways: the TBK1-IRF3 pathway, which primarily drives IFN-I production, and TBK1-related NF-B pathways, which are key for cytokine secretion
doi: 10.1016/j.jep.2020.113704